7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

PolyPid Ltd
(NASDAQ:PYPD) 

PYPD stock logo

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product includes D-PLEX100, which is in Phase 3 clinical trial for the prevention of sternal (bone) s...

Founded: 2008
Full Time Employees: 57
CEO: Amir Weisberg  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
PolyPid Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -19.12-16.39-13.66-10.93-8.19-5.46-2.730
PolyPid Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -19.04-16.32-13.6-10.88-8.16-5.44-2.720
PolyPid Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.881.762.643.524.395.276.15
PolyPid (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -6.49-5.56-4.63-3.71-2.78-1.85-0.930
PolyPid P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -4.69-0.942.86.5510.314.0417.7921.54
No extra charts and metrics for this ticker.